117 related articles for article (PubMed ID: 22300458)
1. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
Tseng CH
BJU Int; 2012 Sep; 110(5):668-73. PubMed ID: 22300458
[TBL] [Abstract][Full Text] [Related]
2. Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes.
Tseng CH
Clin Genitourin Cancer; 2013 Dec; 11(4):508-14. PubMed ID: 23791436
[TBL] [Abstract][Full Text] [Related]
3. Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan.
Tseng CH
Metabolism; 2012 Jul; 61(7):1003-9. PubMed ID: 22237115
[TBL] [Abstract][Full Text] [Related]
4. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
Smooke S; Horwich TB; Fonarow GC
Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.
Lind M; Fahlén M; Eliasson B; Odén A
Prim Care Diabetes; 2012 Apr; 6(1):53-9. PubMed ID: 22056422
[TBL] [Abstract][Full Text] [Related]
6. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
[TBL] [Abstract][Full Text] [Related]
7. Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan.
Tseng CH
Acta Diabetol; 2013 Dec; 50(6):879-86. PubMed ID: 23508375
[TBL] [Abstract][Full Text] [Related]
8. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese.
Tseng CH
Eur J Clin Invest; 2013 Jun; 43(6):595-601. PubMed ID: 23550697
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
11. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
12. Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan.
Tseng CH; Chong CK; Tseng CP; Chan TT
Ann Med; 2009; 41(5):371-9. PubMed ID: 19191082
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
Velicer CM; Dublin S; White E
Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
[TBL] [Abstract][Full Text] [Related]
14. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
[TBL] [Abstract][Full Text] [Related]
15. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.
Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
Cancer Causes Control; 2008 Feb; 19(1):25-31. PubMed ID: 17906959
[TBL] [Abstract][Full Text] [Related]
17. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
Janghorbani M; Amini M
Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
[TBL] [Abstract][Full Text] [Related]
18. Long-term mortality and retinopathy in type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
[TBL] [Abstract][Full Text] [Related]
19. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
